Millie
your market intelligence analyst
Search Results
59 results
Your search is now limited to «Genentech» expert search.
Business Wire 10/21/2019 01:00
About Genentech in personalized cancer immunotherapy For more than 30 years, Genentech has been developing medicines with the goal to redefine treatment in oncology.
More from Business Wire:
Drugs.com 10/17/2019 18:10
About Genentech Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions.
More from Drugs.com:
On October 16, 2019, Genentech sent the following letter to HFA and NHF.
More from Hemophilia Federation of America:
ENDPOINTS 10/14/2019 10:49
Genentech has released data from its Phase III PEMPHIX study evaluating the efficacy and safety of Rituxan (rituximab) compared to mycophenolate mofetil (MMF), in adults with moderate to severe pemphigus vulgaris (PV.
More from ENDPOINTS:
PR Newswire 10/09/2019 03:00
Sosei Heptares and Genentech entered into their collaboration and license agreement in July 2019 to combine the proprietary GPCR-focused structure-based drug design capabilities at Sosei Heptares with Genentech's discovery, development and therapeutic area expertise directed towards multiple GPCR targets nominated by Genentech ...
More from PR Newswire:
Xconomy 10/08/2019 11:57
Merdad Parsey has been appointed chief medical officer of Gilead Sciences (NASDAQ: GILD). The Foster City, CA-based company said Parsey will start his new role on Nov. 1. He will join Gilead from Roche subsidiary Genentech, where he is senior vice president of early clinical development in the company’s Research and Early Development Group. His […]
More from Xconomy:
MarketWatch 10/07/2019 08:40
Gilead Sciences Inc. said Monday it named Merdad Parsey its chief medical officer, effective Nov. 1. Parsey was most recently a senior vice president of early clinical development at Roche Holding AG's Genentech Inc. Merdad will report directly to Chief Executive Daniel O'Day. The biopharmaceutical company's stock, which eased 0.3% in light premarket trading, is little changed year to date through Friday, while the iShares Nasdaq Biotechnology ETF has gained 3.2% and the S&P 500 has advanced 17.8%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Reuters.com 09/27/2019 14:09
Genentech:
More from Reuters.com:
Although Genentech’s BPCIA litigation against Pfizer was short-lived, with the complaint filed just this past April, Genentech remains locked in litigation against Amgen concerning Amgen’s recently launched bevacizumab biosimilar, MVASI.
More from Goodwin Procter BioSimilars Blog:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications